Decrease in Pediatric Invasive Pneumococcal Disease During the COVID-19 Pandemic
Adriana Sarmiento Clemente, Sheldon L. Kaplan, William J. Barson, Philana Ling Lin, José R. Romero, John S. Bradley, Tina Q. Tan, Pia S. Pannaraj, Laurence B. Givner, Kristina G. Hultén
Abstract
Measures to limit SARS-CoV-2 transmission in 2020 reduced other viral infections. Among 7 US children's hospitals, invasive pneumococcal disease cumulative incidence decreased by 46% in 2020 vs 2017-2019. Limited droplet transmission of pneumococci and preceding viral pathogens may be responsible.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)PandemicPneumococcal disease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PneumoniaBetacoronavirusVirologyCoronavirus InfectionsDiseaseIntensive care medicineStreptococcus pneumoniaeInfectious disease (medical specialty)OutbreakInternal medicineMicrobiologyAntibioticsBiologyPneumonia and Respiratory InfectionsRespiratory viral infections researchStreptococcal Infections and Treatments